Audien Atom Pro 2 vs Otofonix Groove

The Audien Atom Pro 2 is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.3/5 in our lab testing. Available for $289, this visible-in-ear device delivers solid performance in some areas while showing limitations in others. In our testing, the Atom Pro 2 demonstrated excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the OTC category average. This means users can expect stable performance without whistling during typical daily activities. Own-voice comfort scored 2.6/5, slightly above the category average, suggesting acceptable naturalness when speaking. However, speech clarity presents a mixed picture. Speech in quiet scored 2.3/5 (0.49 points below category average), and speech in noise scored a low 1.3/5 (0.16 points below average). The most significant limitation is music streaming, which scored 0.0/5—nearly 2 points below the category average—indicating this device is not suitable for those who want to stream audio from their phone. At this price point, several alternatives offer stronger overall performance, including the Elehear Beyond and Apple AirPods Pro 2. The Atom Pro 2 may suit budget-conscious consumers who prioritize feedback-free operation over streaming capabilities and don't need maximum speech clarity. Those seeking better speech performance or any music streaming should consider higher-scoring options in this price range.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.